Rhodium catalyst modifies hydroformylation of protected propargylic alcohols, indicating diverse product outcomes.
A rhodium catalyst modified with a self-assembling pyridone-based phosphine ligand enables a chemoselective hydroformylation of protected propargylic alcohols to furnish either 4-siloxy enals or protected 4-hydroxy aldehydes depending on the reaction conditions.
No takes yet. Share an insight, caveat, or question.
Veith et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: